Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...
A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...
Stacker on MSN
Top science stories of 2025
Knowable Magazine reports 2025 faced turmoil in U.S. science amid job cuts and budget slashes, yet saw advances in gene ...
Scientists have developed a novel approach of genome editing to repair muscle stem (satellite) cells, offering new hope for ...
RRS1, a ribosome-biogenesis factor previously linked to tumor growth, is now shown to be indispensable for normal human ...
QurAlis Corporation ("QurAlis"), a clinical-stage biotechnology company driving scientific breakthroughs into powerful precision medicines that have the potential to alter the trajectory of ...
It wasn’t all doom and gloom in 2025. There were positive developments globally science and climate, in particular.
Clinical Trials Arena on MSN
QurAlis announces Phase I QRL-101 trial topline results in ALS
Kv7.2/7.3 channels are voltage-gated potassium channels involved in regulating membrane potential and neuronal excitability.
Here, readers call on U.S. Senate to stop health insurance premiums from skyrocketing, urge Robert F. Kennedy Jr.'s impeachment, more.
If you’ve wondered what a preamplifier is, what it exactly does, and whether your audio setup is missing one, we’ve got the ...
As the immune system weakens with age, scientists have found a way to restore some of its lost strength. By delivering mRNA ...
This stock is a great choice for cautious and aggressive investors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results